SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001564590-15-007284
Filing Date
2015-08-13
Accepted
2015-08-13 17:10:12
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A xene-10qa_20150331.htm 10-Q/A 1638785
2 EX-31.1 xene-ex311_74.htm EX-31.1 13802
3 EX-31.2 xene-ex312_75.htm EX-31.2 14004
4 EX-32.1 xene-ex321_76.htm EX-32.1 8073
5 EX-32.2 xene-ex322_77.htm EX-32.2 7868
  Complete submission text file 0001564590-15-007284.txt   3973299

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xene-20150331.xml EX-101.INS 609960
7 XBRL TAXONOMY EXTENSION SCHEMA xene-20150331.xsd EX-101.SCH 28146
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20150331_cal.xml EX-101.CAL 27843
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20150331_def.xml EX-101.DEF 73792
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20150331_lab.xml EX-101.LAB 202675
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20150331_pre.xml EX-101.PRE 154584
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36687 | Film No.: 151051534
SIC: 2834 Pharmaceutical Preparations